Display options
Cite
Nishi M, Miyake H, Takeda T, et al. Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases. Eur J Pediatr. 1988;147(3):308-11doi: 10.1007/BF00442702.
Nishi, M., Miyake, H., Takeda, T., Takasugi, N., Sato, Y., & Hanai, J. (1988). Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases. European journal of pediatrics, 147(3), 308-11. https://doi.org/10.1007/BF00442702
Nishi, M, et al. "Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases." European journal of pediatrics vol. 147,3 (1988): 308-11. doi: https://doi.org/10.1007/BF00442702
Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J. Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases. Eur J Pediatr. 1988 Apr;147(3):308-11. doi: 10.1007/BF00442702. PMID: 3391225.
Copy Download .nbib Format: NLM
Share it on

Eur J Pediatr. 1988 Apr;147(3):308-11. doi: 10.1007/BF00442702.

Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases.

European journal of pediatrics

M Nishi, H Miyake, T Takeda, N Takasugi, Y Sato, J Hanai

Affiliations

  1. Department of Public Health, Sapporo Medical College, Japan.

PMID: 3391225 DOI: 10.1007/BF00442702

Abstract

Sixty-eight cases of neuroblastoma detected during mass screening being performed by 11 local self-governing bodies of Japan were studied concerning age, clinical stage, and survival rate. Their average ages at the first screening, at the beginning of thorough examination, and at the start of therapy were 215.7, 245.6, and 264.7 days, respectively. This screening, which is aimed at the 6-month-old infants is considered to be acceptable, on the grounds that the majority of the cases (95.6%) were asymptomatic at the time of thorough examination, that for most of the cases (98.5%) the initiation of therapy was at under 1 year of age, and that their 60-month survival rate was 87.5%. However, there seems to be room for discussion of the best age at which subjects should be screened, because the 68 cases included some patients already with advanced stages at the time of thorough examination, and because "false negative cases" were identified besides the 68 positive cases.

References

  1. Med Pediatr Oncol. 1984;12(2):101-3 - PubMed
  2. Jpn J Clin Oncol. 1986 Dec;16(4):351-5 - PubMed
  3. Lancet. 1984 Aug 4;2(8397):271-3 - PubMed
  4. Cancer. 1987 Aug 1;60(3):433-6 - PubMed
  5. Am J Pediatr Hematol Oncol. 1984 Fall;6(3):233-43 - PubMed
  6. Cancer. 1971 Feb;27(2):374-8 - PubMed
  7. Tohoku J Exp Med. 1986 Oct;150(2):169-74 - PubMed
  8. Lancet. 1971 May 22;1(7708):1046-9 - PubMed
  9. Am J Dis Child. 1982 Aug;136(8):710-2 - PubMed
  10. Cancer. 1980 Oct 15;46(8):1896-1901 - PubMed
  11. Am J Public Health. 1985 Feb;75(2):173-5 - PubMed
  12. Cancer. 1984 Jun 15;53(12):2731-5 - PubMed
  13. Cancer. 1984 May 15;53(10):2079-82 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources